Platelet-rich plasma collection and preparation: a retrospective analysis of 256 cases
10.13303/j.cjbt.issn.1004-549x.2023.10.021
- VernacularTitle:富血小板血浆采集制备及质量控制的回顾性分析
- Author:
Lijuan YANG
1
;
Yan HU
1
;
Yajuan WU
1
;
Li ZHANG
1
;
Liping LIU
1
;
Tao PENG
1
;
Xinyu GAN
1
Author Information
1. Department of Blood Transfusion,the General Hospital of Western Theater Command, Chengdu 610036, China
- Publication Type:Journal Article
- Keywords:
quality/platelet-rich plasma(PRP);
plasma collection;
blood cell separator
- From:
Chinese Journal of Blood Transfusion
2023;36(10):946-948
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To retrospectively analyze the safety and product quality of NGL XCF 3000 blood cell separator for collecting platelet-rich plasma (PRP) in 256 cases, so as to provide reference for safe collection and product quality control of PRP. 【Methods】 The data of 256 patients receiving PRP treatment in our hospital from June 2021 to June 2022 were statistically analyzed, and the differences in the collection time, circulating blood volume and the occurrence of adverse reactions to blood donation were analyzed when NGL XCF 3000 was used to collect autologous PRP among patients of different genders, ages and platelet counts. The differences in platelet content, red blood cell(RBC) contamination and white blood cell(WBC) residues in PRP products were analized. 【Results】 1) There were no significant differences in collection time, circulating blood volume and collection volume among patients of different genders, ages and platelet counts (P<0.05). 2) The contents of WBC, RBC and platelet were not significantly different between male and female patients after collection (P<0.05); 3) The WBC contents increased with the increase of age, and the WBC residue in the elder group[ 56 to78 years old, (0.64±0.41) ×109/L] was significantly higher than that in the younger group[group 1,18 to 40 years old, (0.50±0.35)×109/L], with significant difference was Statistically significant (P<0.05). 4) The residues of WBCs and RBCs in in low platelet group [group 1, (100-150)×109/L] were higher than those in other platelet count groups, and the difference was Statistically significant (P<0.05), and the platelet count in this product was significantly lower than that in other platelet count groups (P<0.05). Conclusion The NGL XCF 3000 blood cell separator is safe and stable for PRP collection in patients with different genders, ages and platelet counts of (100-450)×109/L, and the PRP products collected can meet clinical therapeutic needs.
